Cargando…

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documente...

Descripción completa

Detalles Bibliográficos
Autores principales: Defty, Helen, Sames, Edward, Doherty, Teresa, Hughes, Rodney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615585/
https://www.ncbi.nlm.nih.gov/pubmed/23573450
http://dx.doi.org/10.1155/2013/728371
_version_ 1782265019343306752
author Defty, Helen
Sames, Edward
Doherty, Teresa
Hughes, Rodney
author_facet Defty, Helen
Sames, Edward
Doherty, Teresa
Hughes, Rodney
author_sort Defty, Helen
collection PubMed
description Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.
format Online
Article
Text
id pubmed-3615585
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36155852013-04-09 Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis Defty, Helen Sames, Edward Doherty, Teresa Hughes, Rodney Case Rep Rheumatol Case Report Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years. Hindawi Publishing Corporation 2013 2013-03-19 /pmc/articles/PMC3615585/ /pubmed/23573450 http://dx.doi.org/10.1155/2013/728371 Text en Copyright © 2013 Helen Defty et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Defty, Helen
Sames, Edward
Doherty, Teresa
Hughes, Rodney
Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title_full Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title_fullStr Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title_full_unstemmed Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title_short Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
title_sort case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615585/
https://www.ncbi.nlm.nih.gov/pubmed/23573450
http://dx.doi.org/10.1155/2013/728371
work_keys_str_mv AT deftyhelen casereportoftransversemyelitisinapatientreceivingetanerceptforrheumatoidarthritis
AT samesedward casereportoftransversemyelitisinapatientreceivingetanerceptforrheumatoidarthritis
AT dohertyteresa casereportoftransversemyelitisinapatientreceivingetanerceptforrheumatoidarthritis
AT hughesrodney casereportoftransversemyelitisinapatientreceivingetanerceptforrheumatoidarthritis